loader

prct

LATEST ARTICLES

PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026

PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval

AUA Guidelines Strengthen Recommendation for Aquablation® Therapy

PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June

PROCEPT BioRobotics Reports First Quarter 2026 Financial Results

PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026

Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems

EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH

PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy

PRCT: Guided $325.5M, Hid Pricing Headwind -- Levi & Korsinsky, LLP Investigates

PRCT: $50.2M ADJUSTED EBITDA LOSS VS. $35M PROJECTED -- LEVI & KORSINSKY, LLP INVESTIGATES

PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES